Find & Optimize Novel Vectors to Increase Specificity, Target New Cell Types, Expand Packaging Capacities & Reduce Toxicity Risks to Create Safer, Cost-Effective & Efficacious Gene Therapies

Welcome to the 4th Next Generation Gene Therapy Vectors Summit

Innovating Gene Therapy Capsid & Payload Design

As the first wave of gene therapy programs continue to progress into and through the clinic, attention turns to finding and optimizing the next generation of improved vector candidates. With delivery challenges cited by many as the limiting factor for progress in the field, significant investment continues to pour into improving the safety, efficacy, and predictability of delivery platforms.

In this setting, the 4th Next Generation Gene Therapy Vectors Summit is returning as the only industry-focused event covering the latest advances and innovations in vector development for gene therapies.

90+ biopharma and academic pioneers will be uniting to share data-driven examples of how they are improving the new wave of viral gene therapy vectors, as well as sharing highly translatable insights into the latest disruptive non-viral platforms.

If you are working towards the end goal of developing safe, predictable, cost-effective, scalable, and tissue-specific platforms that can deliver to a diverse range of cell types, join the world’s experts in Boston to keep your finger on the pulse and support your vector development efforts for 2024 and beyond.

10

New Tech Pieces

14

New Data Readouts

17

New Groups Speaking

25+

Expert Speakers

60+

Companies Represented

90+

Attendees to Network With

Testimonials From Our Previous Attendees:

“It was the perfect opportunity to learn, ask questions, engage in discussions, and establish relationships with scientists and companies in the field”

Regeneron

 

“Extremely comprehensive and varied subject matter, and small, intimate setting that fostered open and productive scientific and personal interactions”

University of Florida

2024 World-Class Speaker Faculty Includes:

Companies on the 2024 Program Include:

Who Attends?

Screenshot 2024-02-29 085606